# OnCo record zuma-5 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/zuma-5/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "zuma-5", "NCT03105336" ;
  schema:name "ZUMA-5"@en ;
  schema:description "ZUMA-5 showed that a single infusion of CD19 CAR-T cells put most people with heavily pretreated follicular lymphoma into remission, and that many of those remissions have lasted for years."@en ;
  schema:url <https://onco.cc/trials/zuma-5/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03105336> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "2" ;
  schema:startDate "2017-06-06" ;
  onco:related <https://onco.cc/roadmaps/lymphoma-roadmap/>, <https://onco.cc/trials/elara/>, <https://onco.cc/terms/lymphoma-tx-pod24/> ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/marginal-zone-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:drugs <https://onco.cc/drugs/axicabtagene-ciloleucel/> ;
  onco:companies <https://onco.cc/companies/gilead/> ;
  onco:people <https://onco.cc/people/caron-jacobson/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-zuma-5-axi-cel-indolent-lymphoma-lancet-oncol-2022/> .